Montelukast Sodium Granule
Product Images NDC 27241-015

This is a description of a medication called Montelukast Sodium. The medication comes in the form of 30 tablets with dosage instructions provided in the accompanying product literature. The packaging of the medication is child-resistant and should be stored at a temperature range of 20°C to 25°C; excursions permitted to 15°C to 30°C. Each tablet of Montelukast contains 10.4 mg of the active ingredient Montelukast Sodium USP equivalent to 10 mg Montelukast. The medication should be stored in its original package, away from moisture and light. It is important to keep the medication out of reach of children. Each patient should be given the accompanying medication guide. The medication is marketed by Ajanta Pharma USA Inc. located in Bridgewater, NJ 08807 and it is made in India.*

This is a medication (Montelukast Sodium) that comes in a package with 90 tablets. The package is child-resistant and should be kept out of reach of children. The tablets need to be stored at a temperature between 20°C to 25°C, with excursions permitted to 15°C to 30°C. It's important to protect the tablets from moisture and light by storing them in the original packaging. The medication guide should be dispensed to each patient by a pharmacist. Each tablet contains 10.4 mg of Montelukast Sodium USP, equivalent to 10 mg Montelukast. The medication is made in India and marketed by Ajanta Pharma USA Inc.*

Dosage information is provided in product literature. The package is child-resistant and should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The product should also be protected from moisture and light and stored in its original package. This medication contains phenylalanine and is intended for pediatric patients aged 2-5 years old. It is manufactured by Ajanta Pharma USA Inc. in India. The package code is MH/DRUGS/AD/018 and the NDC is 27241-016-03 for 30 chewable tablets containing 4.2 mg of Montelukast Sodium USP per tablet. Pharmacists are advised to dispense the accompanying medication guide to each patient.*

This is a medication package for Montelukast Sodium Chewable Tablets, USP from Ajanta Pharma USA Inc. It contains 90 tablets and is marketed for pediatric patients between the ages of 2-5 years. The package contains instructions to store it at 20°C to 25°C and to be kept away from children. It also includes a warning for Phenylketonurics who should know that it contains phenylalanine (a component of aspartame) at 0.449 mg per 4 mg chewable tablet. The package also denotes that each tablet contains 4.2 mg Montelukast Sodium USP, equivalent to 4 mg Montelukast. The dosage is to be seen via accompanying product literature.*

This text provides dosage instructions and storage guidelines for Montelukast Sodium Chewable Tablets for pediatric patients between 6-14 years of age. The package is child-resistant and should be stored at 20°C to 25°C (68°F to 77°F) with protection from moisture and light. The tablets also contain phenylalanine and each tablet contains 5.2 mg Montelukast Sodium USP equivalent to 5 mg Montelukast. The tablets are marketed by Ajanta Pharma USA Inc. and made in India. A medication guide should be dispensed to each patient. Code No. and NDC numbers are also provided.*

This is a description of a medication called Montelukast Sodium which comes in the form of chewable tablets. The recommended storage temperature is between 20°C to 25°C, with a permissible variation of 15°C to 30°C. It is essential to store the medication in the original packaging, away from moisture and light, and out of reach of children. The product contains phenylalanine and should not be used by individuals with phenylketonuria. This medication guide should be dispensed by a pharmacist for pediatric patients who are between six and 14 years old. The drug is manufactured by Ajanta Pharma USA, Inc., and is equivalent to 5 mg of Montelukast. Unfortunately, no information is given on what condition this medication treats.*

This is a graph displaying the change in height (in centimeters) with weeks on treatment. The treatment includes the medications Montelukast sodium and Beclomethasone 336 mg, as well as a control group using a placebo. The graph shows that there is minimal change in height over time, but the standard errors of the treatment group means are too small to be visible on the plot.*

Not available.*